Registration - In-house Corporation

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Registration Information

In-house Corporation name: AbbVie Corporation
Previous in-house corporation names
Responsible Officer Name: RAMI FAYED, Vice President and General Manager, Canada
Responsible Officer Change History
Initial registration start date: 2007-04-25
Registration status: Active
Registration Number: 957373-15270

Associated Communications

Total Number of Communication Reports: 149

Monthly communication reports in the last 6 months: 2

Version 11 of 43 (2012-03-01 to 2013-04-25)

Registration versions:

Version 11 of 43 (2012-03-01 to 2013-04-25)

Lobbying Information

Subject Matters

Aboriginal Affairs
Health
Industry
Intellectual Property
International Trade
Science and Technology
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Pharmaceutical intellectual property proposals that are part of the Comprehensive Economic and Trade Agreement with the European Union.

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Acts that propose to amend the Food and Drug Act and amendments to the Food and Drug Regulations related to the regulation of pharmaceuticals, biologic therapies, medical devices and foods.

Legislative Proposal, Bill or Resolution, Regulation

Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs

Policies or Program

Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement

Regulation

Industry Canada Patented Medicines Notice of Compliance (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs
Patented Medicine Prices Review Board (PMPRB) Regulations. with regard to prices charged by patentees for patented medicines sold in Canada.

Communication Techniques

Written communication
Oral communication

Government Institutions

Aboriginal Affairs and Northern Development Canada
Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
House of Commons
Immigration and Refugee Board (IRB)
Industry Canada
National Defence (DND)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Public Works and Government Services Canada
Royal Canadian Mounted Police (RCMP)
Veterans Affairs Canada (VAC)

In-house Corporation Details

Description of activities

Abbott is a broad-based health care company that discovers, develops, manufacturers and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, nutritionals for children and adults, and pharmaceuticals.

Responsible officer name and position during the period of this registration

Felipe Pastrana, General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
8401 Transcanada Highway
St-Laurent, QC H4S 1Z1
Canada

Telephone number: 514-832-7126
Fax number: 514-832-7858

Parent Company Information

Abbott Laboratories
- 100 Abbott Park Rd
  Abbott Park, IL 60064-3500
  United States of America

Subsidiary Beneficiary Information

Abbott Laboratories does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Linda Assouline, Associate Medical Director | No public offices held
Loretta Del Bosco, Director, Regulatory Affairs & Quality Assurance | No public offices held
Laurie Dotto, Director Government & External Affairs | No public offices held
Caroline Jacques, Senior Counsel, Latin America, Canada | No public offices held
Dr Tom Koutsavlis, Medical Director | No public offices held
David Link, National Manager Market Access & Governmental Affairs | No public offices held
Judith Mergl, Senior Manager Regulatory Affairs | No public offices held
Diana Parison, Senior Manager Market Access Planning & HE | No public offices held
Felipe Pastrana, General Manager | No public offices held
Andrew Wynn, Provincial Affairs Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Philip Schwab, Senior Manager, Federal Government Affairs | No public offices held

AbbVie Corporation

The following names have been used on or after July 2, 2008

Name	From	To
AbbVie Corporation	2013-04-25	current
Abbott Laboratories	2008-07-02	2013-04-25

The following names have been used before July 2, 2008

Abbott Laboratories
Abbott Laboratories, Limited

AbbVie Corporation

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
RAMI FAYED	2024-02-01	Current
Tracey Ramsay	2021-02-01	2024-02-01
Denis Hello	2020-03-01	2021-02-01
Stéphane Lassignardie	2015-01-05	2020-03-01
Felipe Pastrana	2011-04-01	2015-01-05
Jeffrey Devlin	2007-04-25	2011-04-01

Date Modified:: 2025-06-03

Search and menus

Language selection

Registration - In-house Corporation

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Registration Information

Associated Communications

Version 11 of 43 (2012-03-01 to 2013-04-25)

Version 11 of 43 (2012-03-01 to 2013-04-25)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties